По вашему запросу найдено документов: 390

Страница 1 из 39

EFFICACY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATABASE RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Zelinska, N., Skorodok, J., Skorodok, J., Malievsky, O., Rosenfeld, R.G., Zadik, Z., Koren, R., Vander, S., Hart, G., Raduk, D. (2016)
EFFICACY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results
Maniatis, AK;, Casella, SJ;, Nadgir, UM;, Hofman, PL;, Saenger, P;, Chertock, ED;, Aghajanova, EM;, Korpal-Szczyrska, M;, Vlachopapadopoulou, E;, Malievskiy, O;, Chaychenko, T;, Cappa, M;, Song, WJ;, Mao, M;, Mygind, PH;, Smith, AR;, Chessler, S;, Komirenko, AS;, Beckert, M;, Aimee, D Shu, Paul, S Thornton (2022)
the long-term safety and efficacy of weekly administered long-acting growth hormone lonapegsomatropin
Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
Deal, C, Steelman, J, Vlachopapadopoulou, E, Stawerska, R, Silverman, LA;, Phillip, M, Kim, HS, Ko, CW, Malievskiy, O, Cara, JF, Roland, CL, Taylor, CT, Valluri, SR, Wajnrajch, MP, Pastrak, A, Miller, BS (2022)
Context: Somatrogon is a long-acting recombinant human growth hormone (rhGH) in development
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
Zadik, Zvi, Zelinska, Nataliya, Iotova, Violeta, Skorodok, Yulia, Malievsky, Oleg, Mauras, Nelly, Valluri, Srinivas Rao, Pastrak, Aleksandra, Rosenfeld, Ron (2023)
Objectives: Somatrogon is a long-acting recombinant human growth hormone (GH) employed as a once
Comparing the efficacy and safety of weekly somatrogon with daily somatropin to treat children with growth hormone deficiency: a plain language summary of publication
Deal, Cheri L., Steelman, Joel, Vlachopapadopoulou, Elpis, Stawerska, Renata, Silverman, Lawrence A., Phillip, Moshe, Kim, Ho-Seong, Ko, CheolWoo, Malievskiy, Oleg, Cara, Jose F., Roland, Carl L., Taylor, Carrie Turich, Valluri, Srinivas Rao, Wajnrajch, Michael P., Pastrak, Aleksandra, Miller, Bradley S. (2024)
injections to treat children who don’t make enough growth hormone to grow adequately. ○ Efficacy refers
A HYBRID FC-FUSED HUMAN GROWTH HORMONE, GX-H9, SHOWS A POTENTIAL FOR WEEKLY AND TWICE-MONTHLY ADMINISTRATION IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Mykola, A., Malievskiy, O, Nataliya, Z, Bolshova, EV, Senatorova, G, Oroszlan, G, Skorodok, J, Peterkova, V, Nataliya, C, Sorokman, T, Yang, S, Lee, JE, Muzsnai, A, Hwang, JS, Kim, T, Choi, YJ, Woo, J, Jang, WI, Sung, YC, Keyoung, M (2017)
A HYBRID FC-FUSED HUMAN GROWTH HORMONE, GX-H9, SHOWS A POTENTIAL FOR WEEKLY AND TWICE
Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results
Maniatis, Aristides K., Thornton, Paul S., Nadgir, Ulhas M., Vlachopapadopoulou, Elpis, Malievskiy, Oleg, Aghajanova, Elena M., Korpal-Szczyrska, Maria, Woods, Katie A., Mao, Meng, Zhao, Carol, Abdelrahman, Sohair G., Huang, Eric A., Komirenko, Allison S., Shu, Aimee D., Shu, A.D., Hofman, Paul (2025)
-term safety and efficacy of once-weekly lonapegsomatropin in children with growth hormone deficiency (GHD
SAFETY AND TOLERABILITY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATASET RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Zelinska, N., Skorodokb, J., Malievsky, O., Rosenfeldd, Ron G., Zadike, Zvi, Korenf, R., Vanderf, Sh., Hartf, G., Radziukg, K. (2016)
Background: Daily injections are currently required for growth hormone (GH) replacement therapy
Enhancers of mesenchymal stem cell stemness and therapeutic potency
Al-Azab, Mahmoud, Idiiatullina, Elina, Safi, Mohammed, Hezam, Kamal (2023)
of MSCs in cellular therapy. Treatment of MSCs utilizing pharmaceutical compounds, cytokines, growth
РОССИЙСКИЙ НАЦИОНАЛЬНЫЙ КОНСЕНСУС. ДИАГНОСТИКА И ЛЕЧЕНИЕ ГИПОПИТУИТАРИЗМА У ДЕТЕЙ И ПОДРОСТКОВ
RUSSIAN NATIONAL CONSENSUS. DIAGNOSTICS AND TREATMENT OF HYPOPITUITARISM IN CHILDREN AND ADOLESCENCES
НАГАЕВА, Е. В., ШИРЯЕВА, Т. Ю., ПЕТЕРКОВА, В. А., БЕЗЛЕПКИНА, О. Б., ТЮЛЬПАКОВ, А. Н., СТРЕБКОВА, Н.А., КИЯЕВ А. В., ПЕТРЯЙКИНА, Е. Е., БАШНИНА, Е. Б., МАЛИЕВСКИЙ, О. А., ТАРАНУШЕНКО, Т. Е., КОСТРОВА, И. Б., ШАПКИНА, Л. А., ДЕДОВ, И. И., Nagaeva E. V., Shiryaeva T. Y., Peterkova V. A., Bezlepkina O. B., Tiulpakov A. N., Strebkova N.A., Kiiaev A. V., Petryaykina E. E., Bashnina E. B., Мalievsky O. A., Тaranushenko Т. Е., Коstrova I. B., Shapkina L. A., Dedov I. I. (2018)
GROWTH HORMONE DEFICIENCY

Страница 1 из 39

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год